Exon 2 was targeted with an sgRNA using CRISPR/Cas9 technology, resulting in a 49 bp deletion. Western blot and immunohistochemistry experiments confirmed the lack of peptide expression from this allele in testes. (J:307539)
查看原文 参与反馈
Exon 2 was targeted with an sgRNA using CRISPR/Cas9 technology, resulting in a 49 bp deletion. Western blot and immunohistochemistry experiments confirmed the lack of peptide expression from this allele in testes. (J:307539)